Fresh additions to the Afya Chain catalogue, ready for discovery and procurement.
Formulations: - Oral > Solid > tablet: 2.5 mg (as sodium salt); 10 mg (as sodium salt) - Oral > Solid > tablet: 2.5 mg (as sodium salt) - Parenteral > General injections > SC: pre-filled syringe in multiple strengths Indications: - Psoriasis of unspecified type - Rheumatoid arthritis, serology unspecified - Crohn disease site - Psoriatic arthritis - Juvenile idiopathic arthritis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 50 mg in vial powder for injection; 100 mg in vial powder for injection; 50 mg per 10 mL in 10 mL vial; 100 mg per 20 mL in 20 mL vial; 200 mg per 40 mL in 40 mL vial Indications: - Malignant neoplasm metastasis in large intestine - Malignant neoplasms of colon Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 6 mg per mL Indications: - Other specified malignant neoplasms of the ovary - Other specified malignant neoplasms of bronchus or lung - Malignant neoplasms of nasopharynx - Kaposi sarcoma of unspecified primary site - Other specified malignant neoplasms of breast - Other specified carcinomas of ovary - Malignant neoplasms of breast - Malignant neoplasms of cervix uteri Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 3750 units per 5 mL in vial; 3750 units in vial powder for injection Indications: - Lymphoid leukaemia, not elsewhere classified Source: EML workbook import
Formulations: - Oral > Solid: 50 mg (as hydrochloride) Oral > Solid > capsule: 50 mg (as hydrochloride) Indications: - Unspecified malignant neoplasms of ill-defined or unspecified sites - Hodgkin lymphoma Source: EML workbook import
Formulations: - Oral > Solid: 270 mg (containing tetra-arsenic tetra-sulfide 30 mg) Indications: - Acute myeloid leukaemia with recurrent genetic abnormalities Source: EML workbook import
Formulations: - Oral > Solid: 40 mg Indications: - Lymphoid leukaemia, not elsewhere classified Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate) Parenteral > General injections > IV: 10 mg in vial (vinblastine sulfate); 10 mg per 10 mL in vial (vinblastine sulfate) Indications: - Unspecified malignant neoplasms of ill-defined or unspecified sites - Other specified gliomas of brain - Hodgkin lymphoma - Other specified malignant neoplasms of the ovary - Germ cell tumour of testis - Kaposi sarcoma of unspecified primary site - Anaplastic large cell lymphoma, ALK-negative - Anaplastic large cell lymphoma, ALK-positive - Langerhans cell histiocytosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate) Parenteral > General injections > IV: 1 mg in vial (vincristine sulfate); 5 mg in vial (vincristine sulfate); 1 mg per mL in vial (vincristine sulfate); 2 mg per 2 mL in vial (vincristine sulfate) Indications: - Unspecified malignant neoplasms of ill-defined or unspecified sites - Other specified gliomas of brain - Follicular lymphoma - Malignant trophoblastic neoplasms of placenta - Diffuse large B-cell lymphoma, not otherwise specified - Kaposi sarcoma of unspecified primary site - Rhabdomyosarcoma primary site - Hodgkin lymphoma - Burkitt lymphoma including Burkitt leukaemia - Ewing sarcoma of bone and articular cartilage of unspecified sites - Malignant neoplasms of kidney, except renal pelvis - Lymphoid leukaemia, not elsewhere classified - Retinoblastoma - Langerhans cell histiocytosis Source: EML workbook import
Formulations: - Parenteral > General injections > IV: 10 mg per mL in 1 mL vial; 10 mg per mL in 5 mL vial Parenteral > General injections > IV: 10 mg per mL in 1 mL vial; 10 mg per mL in 5 mL vial Oral > Solid > capsule: 20 mg; 30 mg; 80 mg Indications: - Other specified malignant neoplasms of bronchus or lung - Other specified malignant neoplasms of breast - Rhabdomyosarcoma primary site Source: EML workbook import
Formulations: - Local > Dental > Gel: 2500 to 12500 ppm fluoride (any type) Local > Dental > Toothpaste, cream or gel: 1000 to 1500 ppm fluoride (any type) Local > Dental > Mouthrinse: 230 to 900 ppm fluoride (any type) Local > Dental > Varnish: 22500 ppm fluoride (any type) Indications: - Dental caries Source: EML workbook import
Formulations: - Local > Dental > Powder + liquid: Single-use capsules: 0.4 g powder + 0.09 mL liquid; Multi-use bottle: powder + liquid Indications: - Dental caries Source: EML workbook import
Ready to amplify your rewards? Drop your email and we'll be in touch soon.
